Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Effectiveness Both medicines have been shown in clinical trials to be highly effective at helping people lose weight, with Mounjaro (tirzepatide) helping people lose 22.5% of their starting weight on average, and Ozempic/Wegovy (semaglutide) helping people lose around 21% of starting weight
And if longevity really is your goal, embrace eating a nutritious diet, exercising regularly, and getting enough sleep each night
The main visual differences are in the delivery devices rather than the solutions themselves
Some providers may adjust your dose based on how your body responds, but you should never go over the approved maximum dose
GLP-1 receptor agonists should only be continued if there is a beneficial metabolic response, defined as a reduction of at least 11 mmol/mol (1.0%) in HbA1c and a weight loss of at least 3% of initial body weight at six months
Impact of semaglutide on biochemical and radiologic measures of metabolic-dysfunction associated fatty liver disease across the spectrum of glycaemia: A meta-analysis
